Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -20.47x is 122% below its 1-year average of -9.24x, near the low end of its 1-year range (-20.47x–-1.33x).
As of the fiscal period ended Sunday, December 31, 2023. 87.84% below its 12-month average of -10.90x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2023 (2023-12-31): -20.47x.
INTEREST COVERAGE RATIO
-20.47x
INTEREST COVERAGE RATIO AVG TTM
-10.90x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-87.84%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-4.99x
median of 387 covered companies
CURRENT VS SECTOR MEDIAN
-310.16%
vs the sector median at left
Invivyd, Inc.
Market Cap
$243.08M
Interest Coverage Ratio
-20.47x
TTM Avg
-10.90x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.95M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$243.81M
Interest Coverage Ratio
0.57x
TTM Avg
0.57x
3Y Avg
0.57x
5Y Avg
0.57x
Market Cap
$238.61M
Interest Coverage Ratio
-1280.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$235.77M
Interest Coverage Ratio
-2.74x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$236.81M
Interest Coverage Ratio
-1.08x
TTM Avg
0.39x
3Y Avg
0.39x
5Y Avg
0.20x
Market Cap
$242.85M
Interest Coverage Ratio
N/A
TTM Avg
0.97x
3Y Avg
1.45x
5Y Avg
67.07x
Market Cap
$235.77M
Interest Coverage Ratio
0.97x
TTM Avg
0.97x
3Y Avg
0.97x
5Y Avg
0.97x
Market Cap
$250.48M
Interest Coverage Ratio
-530.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Invivyd, Inc. (IVVD) | $243.08M | -20.47x | -10.90x | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.95M | N/A | N/A | N/A | N/A |
| Lifecore Biomedical, Inc. (LFCR)vs › | $243.81M | 0.57x | 0.57x | 0.57x | 0.57x |
| InflaRx N.V. (IFRX)vs › | $238.61M | -1280.37x | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $235.77M | -2.74x | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $236.81M | -1.08x | 0.39x | 0.39x | 0.20x |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $242.85M | N/A | 0.97x | 1.45x | 67.07x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $235.77M | 0.97x | 0.97x | 0.97x | 0.97x |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $250.48M | -530.37x | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $232.73M | -133.11x | N/A | N/A | N/A |
Interest Coverage
-20.5x
Debt/Equity
0.05
Current Ratio
5.87
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2023-12-31 | -20.47x |
| 2022-12-31 | -1.33x |
| 2022-09-30 | -5.92x |
